Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease.
about
Wheezing in children with sickle cell diseaseSensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠.Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at homePatient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banksHospital utilization and characteristics of patients experiencing recurrent readmissions within children's hospitals.Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.Sickle-cell disease in California: a population-based description of emergency department utilization.Thirty-day readmission rates following hospitalization for pediatric sickle cell crisis at freestanding children's hospitals: risk factors and hospital variation.Development, Validation and Deployment of a Real Time 30 Day Hospital Readmission Risk Assessment Tool in the Maine Healthcare Information ExchangeBlood transfusion and 30-day readmission rate in adult patients hospitalized with sickle cell disease crisis.Hospitalization Events among Children and Adolescents with Sickle Cell Disease in Basra, Iraq.Abnormal pulmonary function and associated risk factors in children and adolescents with sickle cell anemia.Needs Assessment for Patients with Sickle Cell Disease in South Carolina, 2012Pediatric readmission prevalence and variability across hospitalsAdult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management.Chart Card: feasibility of a tool for improving emergency department care in sickle cell disease.An observational study of nurse staffing ratios and hospital readmission among children admitted for common conditions.Hospital Readmission Through the Emergency DepartmentHydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities.Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate.Improving outcomes in children with sickle cell disease: treatment considerations and strategies.A framework of pediatric hospital discharge care informed by legislation, research, and practice.Opioid prescription practices at discharge and 30-day returns in children with sickle cell disease and pain.Association of Guideline-Adherent Antibiotic Treatment With Readmission of Children With Sickle Cell Disease Hospitalized With Acute Chest Syndrome.A Mixed-Methods Study of Pain-related Quality of Life in Sickle Cell Vaso-Occlusive Crises.Outpatient follow-up and rehospitalizations for sickle cell disease patients.Spirometric Evaluation of Pulmonary Function in Nigerian Children underwent Bone Marrow Transplantation for Sickle Cell Anemia.Care of children with sickle cell disease in the emergency department: parent and provider perspectives inform quality improvement efforts.Ambulatory care connections of Medicaid-insured children with sickle cell disease.Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6-year population-based cohort study.
P2860
Q27012863-5559930F-5EC2-4F48-A62E-3EE064A09EB0Q33755816-AF064128-E502-4CB5-A74A-1E687F8ADC4FQ34424675-956FC908-E43B-4B4B-8EC0-8F6B522B15EAQ34570608-82F1EE13-A8A1-4F7D-A6E0-AF247E3A7BCBQ35055378-7ECF35B2-8EF1-4A21-927A-3EA743C25AFCQ35533604-06048B59-82EA-4C9E-9B8B-C45C174F3FA1Q35778071-90706A3A-13CC-4630-B0FA-6D1AD461EBD7Q36089190-468D8AEE-8017-4BA2-A209-6B876EF1A53FQ36136496-08684887-020F-4B21-B0D1-0596F55A868EQ36161782-39084F90-36F8-4D7F-8D21-79E184EBD685Q36260983-D4F02D6B-EAA6-4FA8-8015-BB160B0E908DQ36377080-5A05E3DB-FE6E-4246-BBF7-44BF2D2D1DA7Q36472782-7F4F6B43-1E8D-45CD-BE79-FE437C9D08BAQ36808387-9452AFA7-A4EF-4D37-B1E2-6268AE96FF15Q36951154-E31443A4-1737-4A13-B6D9-61547D0AD4DAQ37108110-8EC85707-160E-4D79-A8CF-2F48B71665C6Q37130064-449C29E6-47E2-43AD-B4E2-B757CB790C80Q37214235-9EC5D5F9-5560-431B-83E2-24D93E477941Q37223344-DBA64AFA-0710-4ED1-A7B2-3BA59465B407Q37293026-FC4FA2A1-D21E-4FC5-88DA-67DF331C2A44Q38209472-D25B7EF4-D64B-4DD3-9935-99B5E02EB71EQ38243062-037F051D-533C-4D0F-9281-E70C165830A3Q39228441-7311E1D6-F006-442C-B40D-005ED25A345AQ40053629-FE9B2C4F-D543-4451-90EA-AAB99DB1D777Q41638889-A3C71FAD-1546-45FE-A26E-CFC4E1ABAF31Q41982685-B2D27E32-E4AE-4E4A-936C-68CCE702AFE2Q42289448-2C72C7A4-E1BF-43D3-9265-C9BECE6F246CQ43467056-C0A7BEB9-D188-4514-AA3D-2466DE8AB33FQ45390969-B8674EEF-2D0A-4F3D-B23F-3F8815E3CBAEQ54735877-FBD1569A-33B7-4466-A64E-F09E3F462AAF
P2860
Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk factors for hospital read ...... dren with sickle cell disease.
@en
Risk factors for hospital read ...... dren with sickle cell disease.
@nl
type
label
Risk factors for hospital read ...... dren with sickle cell disease.
@en
Risk factors for hospital read ...... dren with sickle cell disease.
@nl
prefLabel
Risk factors for hospital read ...... dren with sickle cell disease.
@en
Risk factors for hospital read ...... dren with sickle cell disease.
@nl
P2093
P2860
P356
P1476
Risk factors for hospital read ...... dren with sickle cell disease.
@en
P2093
Joshua J Field
Melissa J Frei-Jones
Michael R DeBaun
P2860
P304
P356
10.1002/PBC.21854
P577
2009-04-01T00:00:00Z